The Importance of Serological Procalcitonin Levels After Autologous Microsurgical Transplantation

The Journal of Craniofacial Surgery
Ali-Farid SafiMax Zinser

Abstract

Published data on procalcitonin (PCT) levels after microsurgical interventions are very scarce, although infection within these patients is not only associated with severe morbidity but also significantly higher mortality rates. Retrospective study on 20 patients, who were operated on by a single experienced plastic and reconstructive surgeon within one year (June 2017-June 2018). The authors included all patients, who received microvascular transplants for reconstruction of soft tissue defects. Furthermore, age above 18 years and appropriate documentation allowing sufficient data collection were defined as inclusion criteria. The authors excluded all patients with perioperative systemic inflammation and transplant loss, as our aim was to solely determine and evaluate potential alterations of serological PCT levels after microsurgical interventions. The PCT cutoff level to differentiate physiological and pathological levels was defined as 0.1 μg/L. There was no detectable increase in procalcitonin in all of our 20 patients, for whom the authors performed microvascular transplantation to reconstruct soft tissue defects. Serological PCT levels remain stable after the considered surgical interventions and therefore PCT levels migh...Continue Reading

References

Jan 1, 1997·Langenbecks Archiv für Chirurgie·T BertschJ Aufenanger
Jun 29, 2002·Scandinavian Journal of Clinical and Laboratory Investigation·M LindbergK S Bjerve
May 24, 2007·Plastic and Reconstructive Surgery·Duc T BuiBabak J Mehrara
Oct 22, 2008·Journal of Cardiac Surgery·Navid MadershahianThorsten Wahlers
Nov 26, 2010·Journal of Reconstructive Microsurgery·Christian HeroldPeter Maria Vogt
Nov 8, 2011·Medicina intensiva·B SuberviolaB Fernández-Miret
Mar 13, 2013·Diseases of the Colon and Rectum·Alvaro Garcia-GraneroEduardo Garcia-Granero
May 18, 2013·The Korean Journal of Internal Medicine·Hyuck Lee
May 23, 2015·Clinical Transplantation·Uriel SandkovskyDiana F Florescu
Aug 8, 2015·Microsurgery·Thomas MückeDenys J Loeffelbein
Aug 17, 2016·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Thomas MückeDenys J Loeffelbein
Apr 13, 2017·International Journal of Oral and Maxillofacial Surgery·S KoerdtM R Kesting
May 29, 2018·Journal of Cranio-maxillo-facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery·Ali-Farid SafiMartin Kauke

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.